Curanex Pharmaceuticals Inc (CURX) › Cash & EquivalentsCuranex Pharmaceuticals Inc (CURX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.Fiscal YearCash & EquivalentsChange YoY2025$5.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share